CYBA C242T polymorphism is associated with obesity and diabetes mellitus in Brazilian hypertensive patients

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages

  Schreiber, R ^a   Ferreira Sae, M C ^a   Tucunduva, A C ^a   Mill, J G ^b   Costa, Felipe O ^a   Krieger, J E ^c   Franchini, K G ^a   Pereira, A C ^c   Nadruz, W ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diabetes mellitus; Hypertension; Metabolic profile; NADPH oxidase; Single nucleotide polymorphism

Indexed keywords

CYTOCHROME B; CYTOCHROME B 245 LIGHT CHAIN; GLUCOSE; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; WAIST CIRCUMFERENCE;

ADULT; AGED; BRAZIL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; CYSTEINE; DIABETES MELLITUS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NADPH OXIDASE; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THREONINE;

EID: 84862680904     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03594.x     Document Type: Article

References (30)

1. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31: S170-S180.
2. Chang YC, Chuang LM. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res 2010; 2: 316-331.
3. Milagro FI, Campión J, Martínez JA. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity 2006; 14: 1118-1123.
4. Griendling KK. Novel NAD(P)H oxidases in the cardiovascular system. Heart 2004; 90: 491-493.
5. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
6. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004; 279: 45935-45941.
7. Zalba G, San José G, Moreno MU, Fortuño A, Díez J. NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxid Redox Signal 2005; 7: 1327-1336.
8. Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, Yasushi T et al. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 2004; 175: 109-115.
9. San José G, Fortuño A, Beloqui O, Díez J, Zalba G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci 2008; 114: 173-182.
10. Di Castelnuovo A, Soccio M, Iacoviello L, Evangelista V, Consoli A, Vanuzzo D et al. The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb Haemost 2008; 99: 594-601.
11. Sales ML, Ferreira MC, Leme CA Jr, Velloso LA, Gallani MC, Colombo RC et al. Non-effect of p22-phox -930A/G polymorphism on end-organ damage in Brazilian hypertensive patients. J Hum Hypertens 2007; 21: 504-506.
12. Sales ML, Schreiber R, Ferreira-Sae MC, Fernandes MN, Piveta CS, Cipolli JA et al. Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women. Am J Hypertens 2010; 23: 649-654.
13. Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004; 65: 1026-1030.
14. The National Cholesterol Education Program Expert Panel. Executive Summary: the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
15. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH Oxidase p22 phox Gene in Patients With Coronary Artery Disease. Circulation 1998; 97: 135-137.
16. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 2000; 86: 391-395.
17. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, Fukuuchi Y. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000; 31: 936-939.
18. Kim KI, Na JE, Kang SY, Cho YS, Choi DJ, Kim CH et al. Impact of NAD(P)H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian. Int J Cardiol 2007; 123: 18-22.
19. Leslie WS, Hankey CR, Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM 2007; 100: 395-404.
20. Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008; 31: 2032-2037.
21. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 201-207.
22. Schreiber R, Ferreira-Sae MC, Ronchi JA, Pio-Magalhães JA, Cipolli JA, Matos-Souza JR et al. The C242T polymorphism of the p22-phox gene (CYBA) is associated with higher left ventricular mass in Brazilian hypertensive patients. BMC Med Genet 2011; 12: 114.
23. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524-529.
24. San José G, Moreno MU, Oliván S, Beloqui O, Fortuño A, Díez J et al. Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 2004; 44: 163-169.
25. Moreno MU, San Jose G, Fortunõ A, Beloqui O, Diez J, Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 2006; 24: 1299-1306.
26. Fan M, Kähönen M, Rontu R, Lehtinen R, Viik J, Niemi M et al. The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study. Am Heart J 2006; 152: 538-542.
27. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004; 27: 303-307.
28. Ochoa MC, Razquin C, Zalba G, Martínez-González MA, Martínez JA, Marti A. G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects. J Physiol Biochem 2008; 64: 127-133.
29. Moreno MU, San Jose G, Fortuno A, Miguel-Carrasco JL, Beloqui O, Diez J et al. The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes. Front Biosci 2011; 3: 1467-1474.
30. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99.